glp 1 drug history of glucagon-like peptide-1 receptor agonists Timeline of GLP-1 discovery and
Description
Varin EM, Mulvihill EE, Baggio LL et al (2019) Distinct neural sites of GLP-1R expression mediate physiological versus pharmacological control of incretin action

Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the liraglutide effect and action in diabetes (LEAD) trials

[DOI] [PubMed] [Google Scholar] 73.Athauda D., Maclagan K., Budnik N., Zampedri L., Hibbert S., Skene S.S., Chowdhury K., Aviles-Olmos I., Limousin P., Foltynie T

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

Epub 2021 Oct 20

Currently, there are limited studies investigating the relationship between SLE and GLP-1RAs
